HoldingsChannel.com
Spectrum Pharmaceuticals insider buying image
The table below summarizes the most recent Spectrum Pharmaceuticals insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why Spectrum Pharmaceuticals insider buys are important for investors to follow.
DateInsiderPriceAmount
11-12-2012
Insider Buy
Joseph Kenneth Keller
EVP & Chief Operating Officer
$10.95
CAGR »
$109,469.00
10,000 shares
1-20-2011
Insider Buy
Brett L. Scott
Acting Chief Financial Officer
$6.04
CAGR »
$24,180.00
4,000 shares
8-13-2010
Insider Buy
George F. Tidmarsh
CSO AND HEAD OF R&D OPERATIONS
$4.03
CAGR »
$20,150.00
5,000 shares
7-6-2010
Insider Buy
Dilip J. Phd Mehta, M.D.
Director
$3.74
CAGR »
$37,367.00
10,000 shares
6-24-2010
Insider Buy
Rajesh C. Shrotriya, M.D.
Chairman, CEO & President
$3.84
CAGR »
$38,367.00
10,000 shares
6-4-2010
Insider Buy
Rajesh C. Shrotriya, M.D.
Chairman, CEO & President
$3.96
CAGR »
$39,603.00
10,000 shares

Also See: Institutional Holders of SPPI
Also See: SEC filings

SPPI Performance Since Insider Purchase
Below we present the annualized performance delivered by Spectrum Pharmaceuticals stock since 11-12-2012 (the date of the most recent insider purchase). The performance of the investment from the time Spectrum Pharmaceuticals insider buying occurred is the ultimate test of whether insiders were right about SPPI being a good buy.

Growth of $10,000.00
With Dividends Reinvested

Start date: 11/12/2012
End date: 05/28/2020
Start price/share: $10.83
End price/share: $2.97
Starting shares: 923.36
Ending shares: 935.60
Dividends reinvested/share: $0.15
Total return: -72.21%
Average Annual Total Return: -15.62%
Starting investment: $10,000.00
Ending investment: $2,777.56
Years: 7.54
 
Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/12/2012
End date: 05/28/2020
Start price/share: $10.83
End price/share: $2.97
Dividends collected/share: $0.15
Total return: -71.19%
Average Annual Total Return: -15.21%
Starting investment: $10,000.00
Ending investment: $2,880.99
Years: 7.54

Spectrum Pharmaceuticals Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Spectrum Pharmaceuticals insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding SPPI

Quotes delayed 20 minutes
Get Free SEC filing alerts for SPPI:
SPPI SEC Filing Email Alerts ServiceExternal link

Other companies seeing insider buying close in time to when the Spectrum Pharmaceuticals Insider Buying occurred are:

BlackRock Health Sciences Trust Insider Buying
Metaldyne Performance Group Insider Buying
Verint Systems Insider Buying
SkyPeople Fruit Juice Insider Buying
Procter and Gamble Insider Buying
Vertex Pharmaceuticals Insider Buying
Franklin Electric Insider Buying
BG Medicine Insider Buying
Constant Contact Insider Buying
PerkinElmer Insider Buying

Spectrum Pharmaceuticals Insider Buying | www.HoldingsChannel.com

Copyright © 2013 - 2020, All Rights Reserved Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.